Over 30 state attorneys general including in Indiana, Kentucky, and Ohio have urged the Federal Food and Drug Administration ...

Years of research and testing are needed to ensure that brand-name drugs such as Mounjaro are safe and effective. This testing can make the drugs expensive. The manufacturer of a brand-name drug ...

The GLP-1 ad wars “Healthy Skepticism” comes weeks after Eli Lilly competitor and Ozempic-maker Novo Nordisk launched a print ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration ...

In December, the FDA declared that Eli Lilly's weight loss and diabetes medication tirzepatide, sold under the brand names Mounjaro and ... as of Feb 18. Suppliers that produce batches of the ...

However, since Mounjaro is not FDA approved for weight loss, the manufacturer does not provide recommended dosages at this time. Zepbound, which contains the same active ingredient as Mounjaro but ...

In December, the FDA declared that shortages of treatments Zepbound and Mounjaro from another drugmaker, Eli Lilly and Co., ...

At the 2024 Academy Awards, Eli Lilly, the manufacturer of blockbuster weight loss drugs including Mounjaro and Zepbound, criticized people for taking GLP-1s without an obesity diagnosis.

The update about the popular semaglutide injections from drug manufacturer Novo Nordisk follows just two months after the FDA said that shortages of tirzepatide injections Zepbound and Mounjaro ...